GBDC Stock +24.76% Since The Golden Star Was Identified GBDC Stock +24.76% Since The Golden Star Was Identified Unlock Golden Star List

Range Low Price High Price Comment
30 days $2.75 $4.97 Thursday, 18th Apr 2024 ALDX stock ended at $3.98. This is 0.252% more than the trading day before Wednesday, 17th Apr 2024. During the day the stock fluctuated 4.63% from a day low at $3.89 to a day high of $4.07.
90 days $2.71 $4.97
52 weeks $1.42 $11.97

Historical Aldeyra Therapeutics prices

Date Open High Low Close Volume
2024-03-13 $2.96 $3.01 $2.88 $2.90 790 849
2024-03-12 $3.27 $3.29 $3.00 $3.01 659 768
2024-03-11 $3.64 $3.69 $3.25 $3.25 761 101
2024-03-08 $3.78 $3.85 $3.47 $3.62 785 814
2024-03-07 $3.94 $3.99 $3.80 $3.85 439 427
2024-03-06 $3.97 $3.99 $3.89 $3.93 277 654
2024-03-05 $4.10 $4.15 $3.92 $3.93 367 605
2024-03-04 $4.25 $4.29 $3.99 $4.07 606 937
2024-03-01 $3.66 $4.34 $3.62 $4.22 1 356 622
2024-02-29 $3.79 $3.83 $3.52 $3.62 401 190
2024-02-28 $3.73 $3.85 $3.65 $3.69 503 259
2024-02-27 $3.73 $3.83 $3.65 $3.77 547 176
2024-02-26 $3.48 $3.66 $3.47 $3.66 350 762
2024-02-23 $3.54 $3.54 $3.45 $3.49 263 953
2024-02-22 $3.35 $3.58 $3.33 $3.54 334 229
2024-02-21 $3.42 $3.47 $3.29 $3.35 242 454
2024-02-20 $3.51 $3.70 $3.42 $3.44 408 714
2024-02-16 $3.58 $3.68 $3.53 $3.59 494 692
2024-02-15 $3.42 $3.60 $3.39 $3.60 554 787
2024-02-14 $3.22 $3.41 $3.20 $3.40 368 276
2024-02-13 $3.36 $3.37 $3.15 $3.18 509 388
2024-02-12 $3.34 $3.42 $3.29 $3.39 368 703
2024-02-09 $3.26 $3.35 $3.24 $3.30 274 599
2024-02-08 $3.24 $3.29 $3.15 $3.23 270 218
2024-02-07 $3.32 $3.32 $3.20 $3.24 322 992
Click to get the best stock tips daily for free!

About Aldeyra Therapeutics

Aldeyra Therapeutics Aldeyra Therapeutics, Inc., a biotechnology company, develops and commercializes medicines for immune-mediated ocular and systemic diseases. The company's lead product candidate is reproxalap, a reactive aldehyde species (RASP)modulator, which is in Phase III clinical trial for the treatment of dry eye diseases and allergic conjunctivitis. It also develops ADX-629, a first-in-class orally administered RASP modulator that is Phase II clinical tria... ALDX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT